Yahoo Web Search

Search results

  1. People also ask

  2. Aug 20, 2021 · According to new data from a large clinical trial, the Johnson & Johnson COVID-19 vaccine is up to 71% percent effective against hospitalization and 96% percent effective against death from the Delta variant.

    • Carla Delgado
  3. Jul 1, 2021 · In the ENSEMBLE trial, Johnson & Johnson’s single-dose COVID-19 vaccine was 85 percent effective against severe/critical disease and demonstrated protection against hospitalization and death. The vaccine was consistently effective across all regions studied globally, including in South Africa and Brazil, where there was a high prevalence of ...

  4. Sep 21, 2021 · Efficacy against hospitalizations related to COVID-19 in the ENSEMBLE trial was 76 percent (CI, 54%-88%; n=16 cases vaccine arm, n=64 cases placebo arm), and efficacy against COVID-19-related deaths was 83 percent (CI, 41%-97%; n=3 cases vaccine arm, n=17 cases placebo arm).

  5. Jul 21, 2021 · With the BNT162b2 vaccine, the effectiveness of two doses was 93.7% (95% CI, 91.6 to 95.3) among persons with the alpha variant and 88.0% (95% CI, 85.3 to 90.1) among those with the delta...

    • Jamielopez L. Bernal, Nick Andrews, Charlotte Gower, Eileen Gallagher, Ruth Simmons, Simon Thelwall,...
    • 2021
  6. Mar 16, 2021 · With the FDA’s emergency use authorization of the Johnson & Johnson vaccine on Feb. 27, the U.S. now has three highly effective vaccines against COVID-19. All three vaccines – Johnson & Johnson, Pfizer, and Moderna – completely prevented hospitalizations and deaths in clinical trials, which is why public health experts are recommending ...

    • johnson & johnson covid-19 vaccine efficacy against delta variant1
    • johnson & johnson covid-19 vaccine efficacy against delta variant2
    • johnson & johnson covid-19 vaccine efficacy against delta variant3
    • johnson & johnson covid-19 vaccine efficacy against delta variant4
  7. Jul 14, 2021 · Johnson & Johnson Single-Shot COVID-19 Vaccine Demonstrated a Durable Immune Response and Elicited Dual Mechanisms of Protection Against Delta and Other SARS-CoV-2 Variants of Concern in Data Published in New England Journal of Medicine. Antibody and T-cell immune responses strong and stable at eight months after immunization.

  8. Aug 6, 2021 · A single dose of the Covid-19 vaccine made by Johnson & Johnson is highly effective in preventing severe illness and death from the Delta and Beta variants of the coronavirus, data from a...

  1. People also search for